We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,264

The Demise of Valeant Pharmaceuticals: A Case Study in Rotten Culture and Business Ethics
  • Volkov Law Group
  • USA
  • April 3 2016

Showing my age again, Woody Allen’s Take the Money and Run included a hilarious scene when Woody’s parents wearing Groucho Marx glasses talk about


eCommerce Regulation, Bitcoin, Anti-Money Laundering, Shadow Insurance, 401(k) Litigation Expect Focus - Vol. IV, Fall 2015
  • Carlton Fields
  • USA
  • December 23 2015

On January 1, 2016, Section 38.6 of the California Insurance Code will take effect permitting consumers to conduct certain life, disability, and


Advice of counsel defense in US v. Lauren Stevens: dismissal of indictment is not necessarily good news for companies
  • Hogan Lovells
  • USA
  • March 25 2011

The indictment last November of former GlaxoSmithKline (GSK) in-house counsel, Lauren Stevens, for purportedly obstructing a U.S. Food and Drug Administration (FDA) investigation into whether GSK marketed Wellbutrin, an anti-depressant drug, off-label, falsifying and concealing documents, and making false statements sent shockwaves through the legal community


Corporate Crime & Investigations Update - 11 January 2016
  • Addleshaw Goddard LLP
  • Ukraine, United Kingdom, USA
  • January 11 2016

Southwark Crown Court ordered Smith and Ouzman Ltd. to pay a total of approximately £2.2 million in relation to bribes paid to public officials for


D.C. Circuit decision in Friedman v. Sebelius overturns exclusions of three Purdue pharma executives
  • Sidley Austin LLP
  • USA
  • August 6 2012

In the pharmaceutical industry, government investigations initiated by whistleblower qui tam complaints canand often doresult in both civil and criminal charges against the company


State AGs in the news
  • Dickstein Shapiro LLP
  • USA
  • June 26 2014

Don Quick (D) and Cynthia Coffman (R) received their respective party's nomination after both ran unopposed in the primary. Incumbent AG John Suthers


The State AG Report Weekly Update January 7, 2016
  • Cozen O'Connor
  • USA
  • January 7 2016

Kansas AG Derek Schmidt reached a settlement with American Handicapped & Disadvantaged Workers, Inc., (“ADHW”) and its president and CEO for


The State AG report weekly update October 15, 2015
  • Cozen O'Connor
  • USA
  • October 15 2015

New York AG Eric Schneiderman announced a partnership with Facebook to use innovative data and analytical methods to aid law enforcement in detecting


Major cases only, please
  • Bracewell LLP
  • USA
  • July 7 2014

At the American Health Lawyers Association meeting last week, Department of Justice officials signaled that the Department may shift to a model of


New indictment of in-house counsel indicates enhanced efforts to hold corporate executives accountable for food and drug law violations
  • Fish & Richardson PC
  • USA
  • November 15 2010

This year, both the Food and Drug Administration (FDA) and Department of Justice have repeatedly signaled to the pharmaceutical and medical device industries that they should expect an increase in the criminal prosecution of individuals for alleged violations of the food and drug laws, with the stated goals of increasing deterrence and greater compliance